Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,652 public trials 850 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Oral Panobinostat Adult Patients DLBCL Relapsed/Refractory Stem Cell Transfusion (ASCT) or Not Eligible for ASCT

NCT01523834

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Azienda Ospedaliera SS. Antonio e Biagio e C. Arrigo Alessandria, Italy
  • Istituto di Ematologia ed Oncologia Medica A. Seragnoli Policlinico S. Orsola Bologna, Italy
  • Spedali Civili Brescia, Italy
  • Ematologia I, A.O.U. San Martino Genova, Italy
View Trial Details
Completed

Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function

NCT00652626

Conditions
AML, Blood Protein Disorders, Cardiovascular Diseases, +28 more
Locations
  • Sutter East Bay Hospitals Berkeley, California, United States
  • Palm Springs Research Institute Hialeah, Florida, United States
  • MCG Cancer Center Augusta, Georgia, United States
  • Joliet Oncology-Hematology Associates, Ltd. Joliet, Illinois, United States
View Trial Details
Completed

A Multiple Dose Opioid Challenge Study

NCT02611752

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Vince and Associates Clinical Research Overland Park, Kansas, United States
  • University of Kentucky Lexington, Kentucky, United States
  • New York Psychiatric Institute New York, United States
View Trial Details
Completed

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

NCT01007448

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Florida Academic Dermatology Centers Miami, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Rush University Chicago, Illinois, United States
View all 17 locations
View Trial Details
Completed

A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma

NCT01169298

Conditions
Adult T-Cell Leukemia-Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations
  • National Kyusyu Cancer Center Fukuoka, Japan
  • Imamura Bun-in Hospital Kagoshima, Japan
  • Kumamoto University Hospital Kumamoto, Japan
  • Nagasaki University Hospital Nagasaki, Japan
View Trial Details

Related conditions